Thus, TRPV1-dependent hampering of AMPAR endocytosis might be a putative mechanism for TRPV1 positive modulation of RhoA, thus contributing to the development of Alzheimer’s disease (Table 3). This evidence concerns the gene TRPV1 and early-onset autosomal dominant Alzheimer disease.